1887

Abstract

The defence of a host against viral infections is strongly influenced by cytokines. We investigated the role of the B-cell stimulating cytokines IL-5 and IL-6, and the immuno-suppressive cytokine IL-10, during primary and secondary immune responses in mice against infection with Friend retrovirus (FV) (). IL-5 mice were comparable to C57BL/6 wild-type mice in their ability to control acute FV infection. In contrast, IL-6 and IL-10 mice showed significantly enhanced virus loads in spleen cells. However, this impaired control of acute FV replication did not alter the long-term control over persistent FV in IL-6 and IL-10 mice. Immunization with a live attenuated vaccine virus prior to challenge protected all three types of cytokine-deficient mice from high levels of spleen virus, despite the finding that the vaccinated IL-5- and IL-6-deficient mice had significantly reduced titres of virus-neutralizing IgG class antibodies. The results indicate that IL-6 and IL-10 contribute to primary immune responses against FV, but are dispensable during persistent infection and vaccine-primed secondary responses.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-6-1349
2001-06-01
2021-10-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/6/0821349a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-6-1349&mimeType=html&fmt=ahah

References

  1. Chen W. F., Zlotnik A. 1991; IL-10: a novel cytotoxic T cell differentiation factor. Journal of Immunology 147:528–534
    [Google Scholar]
  2. Chesebro B., Miyazawa M., Britt W. J. 1990; Host genetic control of spontaneous and induced immunity to Friend murine retrovirus infection. Annual Review of Immunology 8:477–499
    [Google Scholar]
  3. Constant S. L., Bottomly K. 1997; Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annual Review of Immunology 15:297–322
    [Google Scholar]
  4. Dittmer U., Hasenkrug K. J. 2000; Different immunological requirements for protection against acute versus persistent Friend retrovirus infections. Virology 272:177–182
    [Google Scholar]
  5. Dittmer U., Brooks D. M., Hasenkrug K. J. 1998; Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms. Journal of Virology 72:6554–6558
    [Google Scholar]
  6. Dittmer U., Brooks D. M., Hasenkrug K. J. 1999a; Protection against establishment of retroviral persistence by vaccination with a live attenuated virus. Journal of Virology 73:3753–3757
    [Google Scholar]
  7. Dittmer U., Brooks D. M., Hasenkrug K. J. 1999b; Requirement for multiple lymphocyte subsets in protection against retroviral infection by a live attenuated vaccine. Nature Medicine 5:189–193
    [Google Scholar]
  8. Dittmer U., Peterson K. E., Messer R., Stromnes I. M., Race B., Hasenkrug K. J. 2001; The role of IL-4, IL-12, and IFN-γ in primary and vaccine-primed immune responses to Friend retroviral infection. Journal of Virology 75:654–660
    [Google Scholar]
  9. Fiorentino D. F., Zlotnik A., Vieira P., Mosmann T. R., Howard M., Moore K. W., O’Garra A. 1991; IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. Journal of Immunology 146:3444–3451
    [Google Scholar]
  10. Hasenkrug K. J. 1999; Lymphocyte deficiencies increase susceptibility to Friend virus-induced erythroleukemia in Fv-2 genetically resistant mice. Journal of Virology 73:6468–6473
    [Google Scholar]
  11. Hasenkrug K. J., Chesebro B. 1997; Immunity to retroviral infection: the Friend virus model. Proceedings of the National Academy of Sciences, USA 94:7811–7816
    [Google Scholar]
  12. Hasenkrug K. J., Dittmer U. 2000; The role of CD4 and CD8 T cells in recovery and protection from retroviral infection: lessons from the Friend virus model. Virology 272:244–249
    [Google Scholar]
  13. Hasenkrug K. J., Brooks D. M., Chesebro B. 1995; Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness. Proceedings of the National Academy of Sciences, USA 92:10492–10495
    [Google Scholar]
  14. Hasenkrug K. J., Brooks D. M., Dittmer U. 1998a; Critical role for CD4+ T cells in controlling retrovirus replication and spread in persistently infected mice. Journal of Virology 72:6559–6564
    [Google Scholar]
  15. Hasenkrug K. J., Brooks D. M., Robertson M. N., Srinivas R. V., Chesebro B. 1998b; Immunoprotective determinants in Friend murine leukemia virus envelop protein. Virology 248:66–73
    [Google Scholar]
  16. Hoatlin M. E., Kabat D. 1995; Host-range control of a retroviral disease: Friend erythroleukemia. Trends in Microbiology 3:51–57
    [Google Scholar]
  17. Kabat D. 1989; Molecular biology of Friend viral erythroleukemia. Current Topics in Microbiology and Immunology 148:1–42
    [Google Scholar]
  18. Kinashi T., Harada N., Severinson E., Tanabe T., Sideras P., Konishi M., Azuma C., Tominaga A., Bergstedt-Lindqvist S., Takahashi M. and others 1986; Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature 324:70–73
    [Google Scholar]
  19. Kishimoto T. 1989; The biology of interleukin-6. Blood 74:1–10
    [Google Scholar]
  20. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., Zinkernagel R., Bluethmann H., Kohler G. 1994; Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339–342
    [Google Scholar]
  21. Kopf M., Brombacher F., Hodkin P. D., Ramsay A. J., Milbourne E. A., Dai W. J., Ovington K. S., Behm C. A., Köhler G., Young I. G., Matthaei K. I. 1996; IL-5 deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4:15–24
    [Google Scholar]
  22. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. 1993; Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263–274
    [Google Scholar]
  23. LeBlanc R. A., Pesnicak L., Cabral E. S., Godleski M., Straus S. E. 1999; Lack of interleukin-6 (IL-6) enhances susceptibility to infection but does not alter latency or reactivation of herpes simplex virus type 1 in IL-6 knockout mice. Journal of Virology 73:8145–8151
    [Google Scholar]
  24. Lin M. T., Hinton D. R., Parra B., Stohlman S. A., van der Veen R. C. 1998; The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis. Virology 245:270–280
    [Google Scholar]
  25. Miyazawa M., Nishio J., Chesebro B. 1992; Protection against Friend retrovirus-induced leukemia by recombinant vaccinia viruses expressing the gag gene. Journal of Virology 66:4497–4507
    [Google Scholar]
  26. Moore K. W., O’Garra A., de Waal Malefyt R., Vieira P., Mosmann T. R. 1993; Interleukin-10. Annual Review of Immunology 11:165–190
    [Google Scholar]
  27. Moreau-Gachelin F., Tavitian A., Tambourin P. 1988; Spi-1 is a putative oncogene in virally induced murine erythroleukemia. Nature 331:277–280
    [Google Scholar]
  28. Munroe D. G., Peacock J. W., Benchimol S. 1990; Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles. Molecular and Cellular Biology 10:3307–3313
    [Google Scholar]
  29. Persons D. A., Paulson R. F., Loyd M. R., Herley M. T., Bodner S. M., Bernstein A., Correll P. H., Ney P. A. 1999; Fv2 encodes a truncated form of the Stk receptor tyrosine kinase. Nature Genetics 23:159–165
    [Google Scholar]
  30. Peterson K. E., Iwashiro M., Hasenkrug K. J., Chesebro B. 2000; Major histocompatibility complex class I gene controls the generation of gamma interferon-producing CD4+ and CD8+ T cells important for recovery from Friend retrovirus-induced leukemia. Journal of Virology 74:5363–5367
    [Google Scholar]
  31. Ramsay A. J., Husband A. J., Ramshaw I. A., Bao S., Matthaei K. I., Koehler G., Kopf M. 1994; The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264:561–563
    [Google Scholar]
  32. Ramshaw I. A., Ramsay A. J., Karupiah G., Rolph M. S., Mahalingam S., Ruby J. C. 1997; Cytokines and immunity to viral infections. Immunological Review 159:119–135
    [Google Scholar]
  33. Robertson M. N., Spangrude G. J., Hasenkrug K., Perry L., Nishio J., Wehrly K., Chesebro B. 1992; Role and specificity of T-cell subsets in spontaneous recovery from Friend virus-induced leukemia in mice. Journal of Virology 66:3271–3277
    [Google Scholar]
  34. Santin A. D., Hermonat P. L., Ravaggi A., Bellone S., Pecorelli S., Roman J. J., Parham G. P., Cannon M. J. 2000; Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD+ cytotoxic T lymphocytes. Journal of Virology 74:4729–4737
    [Google Scholar]
  35. Super H. J., Brooks D., Hasenkrug K. J., Chesebro B. 1998; Requirement for CD4+ T cells in the Friend murine retrovirus neutralizing antibody response: evidence for functional T cells in genetic low-recovery mice. Journal of Virology 72:9400–9403
    [Google Scholar]
  36. Wendling F., Tambourin P. E. 1978; Oncogenicity of Friend-virus-infected cells: determination of origin of spleen colonies by the H-2 antigens as genetic markers. International Journal of Cancer 22:479–486
    [Google Scholar]
  37. Yokota T., Coffman R. L., Hagiwara H., Rennick D. M., Takebe Y., Yokota K., Gemmell L., Shrader B., Yang G., Meyerson P. and others 1987; Isolation and characterization of lymphokine cDNA clones encoding mouse and human IgA-enhancing factor and eosinophil colony-stimulating factor activities: relationship to interleukin 5. Proceedings of the National Academy of Sciences, USA 84:7388–7392
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-6-1349
Loading
/content/journal/jgv/10.1099/0022-1317-82-6-1349
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error